Citigroup Hosts Biopharma Conference, Wells Fargo Event Also Noted

Citigroup is continuing its engagement with the biopharmaceutical industry through its upcoming 2026 Biopharma Back to School Conference. The event is designed to bring together key players in the sector, offering a platform for companies to share updates and insights.

Seaport Therapeutics has announced its participation in this Citigroup-hosted conference, where it is expected to present its latest developments. This engagement underscores the bank's role in facilitating connections and discussions within the life sciences space.

In addition to its own hosted conference, Citigroup's involvement in industry events was further noted through Seaport Therapeutics' planned appearance at the 21st Annual Wells Fargo Healthcare Conference. This dual participation highlights the broader financial industry's focus on the biopharma sector and the various conferences that serve as important venues for corporate presentations and investor outreach.

These events collectively serve as crucial touchpoints for companies like Seaport Therapeutics to communicate their progress and strategies to a wide audience of investors, analysts, and industry peers. Citigroup's continued organization and participation in such conferences reflect its commitment to supporting the growth and visibility of companies within the healthcare and biopharmaceutical markets.